/
NTRB
$3.19+$0.11 (+3.74%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$37.4M
12M shares
52-week range
$2.80 – $8.63
7% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NASDAQ
CS
Change$-2.54
Nutriband Inc. Common Stock
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
www.nutriband.com- Employees
- 3
- IPO / List date
- Jun 20, 2017
- HQ
- ORLANDO, FL
Held by traders on TradeandTell
No one on the platform currently holds NTRB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NTRB as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2022-08-12 | 7-for-6 |
| 2019-07-24 | 1-for-4reverse |
Recent trades on TradeandTell
No one on the platform has traded NTRB yet.
